Hannover Rueck (HNR1) AI Stock Analysis

• Market Cap: €33.01B
• Dividend Yield: 3.37%
• Average Volume (3M): 112.70K
• Price to Earnings (P/E): 12.2
• Beta (1Y): 0.74
• Revenue Growth: 2.57%
• EPS Growth: 9.75%
• Country: DE
• Employees: 3,895
• Sector: Financial
• Sector Strength: 70
• Industry: Insurance - Reinsurance
• EPS (TTM): 5.61
• Shares Outstanding: 120,597,140
• 10 Day Avg. Volume: 124,930
• 30 Day Avg. Volume: 112,700
• PEG Ratio: 0.91
• Price to Book (P/B): 2.48
• Price to Sales (P/S): 1.20
• P/FCF Ratio: 0.00
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: €294.13
• Price Target Upside: 7.43% Upside
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 9
• EPS Forecast (FY): 22.82
• Revenue Forecast (FY): €27.89B

• Rating: 74 Outperform
• Price Target: €293.00 ▲(7.01% Upside)
• Action: Upgraded Date: 03/15/26
• Date: Action: Upgraded 03/15/26

The score is driven primarily by solid financial strength (healthy profitability, rising ROE, and improving leverage), partially offset by volatility and data/anomaly flags in 2025 cash flow and operating metrics. Technicals add support with an uptrend and positive momentum, while valuation is a tailwind given the moderate P/E and solid dividend yield.

Positive Factors

Rising ROE and profitability

A sustained increase in ROE to ~20% signals improving capital efficiency across underwriting and investments. For a reinsurer this indicates disciplined pricing and reserve management, supporting durable earnings power and the ability to generate shareholder returns over the next several quarters.

Consistent operating cash flow

Stable, multi-year operating cash flow provides a durable funding source for claims, retrocession, dividends, and capital deployment. This predictable cash generation underpins financial flexibility through the reinsurance cycle and supports long-term solvency and strategic investments.

Improving leverage and stronger equity base

A materially lower debt-to-equity ratio and a larger equity base increase capital resilience and capacity to write risk. That stronger balance sheet positions the firm to absorb large losses, meet regulatory requirements, and selectively grow premiums without excessive leverage risk.

Negative Factors

2025 FCF and EBIT anomalies

Reported zero FCF and EBIT/EBITDA in 2025 indicate a data or one-off accounting swing that undermines trend visibility. Such anomalies hinder reliable cash-based forecasting and complicate assessment of sustainable earnings and capital generation over the coming months.

Volatile margins and revenue lumpiness

Significant year-to-year swings in margins and revenue reflect the inherent lumpiness of reinsurance and reserve development. This volatility reduces earnings predictability, making near-term underwriting results and dividend capacity harder to model for investors and management alike.

Exposure to catastrophe and market cycles

Earnings materially depend on catastrophe frequency/severity and cyclical reinsurance pricing. Structural exposure to natural catastrophes and pricing cycles can compress underwriting margins and require capital rebuilding after loss years, posing persistent execution and capital-allocation challenges.

Hannover Rueck Business Overview & Revenue Model

Company Description

Hannover Rück SE, together with its subsidiaries, provides reinsurance products and services worldwide. It operates through Property & Casualty Reinsurance, and Life & Health Reinsurance segments. The company offers property, casualty, facultative, catastrophe XL, structured reinsurance, and insurance-linked securities. It also provides risk solutions for agricultural, livestock, and bloodstock businesses; aviation and space business; and marine and offshore energy business, as well as credit, surety, and political risks reinsurance products. In addition, the company offers group and individual credit life, enhanced annuities, group life and health, and Takaful reinsurance products; and risk solutions in the areas of critical illness, disability, health, longevity, long term care, mortality, and morbidity. Further, it provides various financial solutions, including new-business financing; monetization of embedded value; reserve and solvency relief; and divestiture of non-core businesses. The company was formerly known as Hannover Rückversicherung AG and changed its name to Hannover Rück SE in March 2013. The company was founded in 1966 and is headquartered in Hanover, Germany. Hannover Rück SE is a subsidiary of Talanx AG.

How the Company Makes Money

Hannover Rueck makes money primarily through (1) underwriting income from reinsurance and (2) investment income on the assets it holds to pay future claims. Underwriting income is generated by collecting reinsurance premiums from insurance companies in exchange for assuming a portion of those insurers’ risk. Profitability depends on pricing discipline, risk selection, contract terms (e.g., attachments/limits, exclusions, reinstatements), diversification, and the level of claims (including catastrophe losses in property & casualty lines). In property & casualty reinsurance, revenue comes from premiums on treaties and facultative covers that protect insurers against frequent losses and severe events (e.g., natural catastrophes); earnings fluctuate with loss experience and the reinsurance pricing cycle. In life & health reinsurance, revenue is driven by premiums and fees related to mortality, longevity, morbidity, and health-related risks, often with longer-duration portfolios where results depend on actuarial assumptions, experience (claims), lapse behavior, and reserving. In addition to traditional risk transfer, Hannover Rueck can generate earnings from structured reinsurance and customized solutions where compensation may include explicit fees, financing margins, or experience-based profit commissions, depending on contract design. A second major earnings driver is investment income: the company invests the premium float and technical reserves (typically in a diversified portfolio such as bonds and other assets consistent with regulatory and risk constraints), earning interest, dividends, and realized/unrealized gains; investment results are influenced by market levels, credit spreads, duration positioning, and asset allocation. The company also uses retrocession (reinsurance purchased by the reinsurer) to manage peak exposures; this affects net premiums and net claims volatility, and can improve risk-adjusted returns by limiting downside in large-loss years. Overall, Hannover Rueck’s earnings are a combination of net earned premiums minus claims and operating costs, plus net investment result, with performance influenced by catastrophe activity, reserve development, interest rates, and reinsurance market conditions.

Hannover Rueck Financial Statement Overview

Summary

Strong profitability and improving net income over time, with healthy and rising ROE and a reasonable leverage profile. The score is tempered by volatility and apparent reporting inconsistencies (notably 2025 EBIT/EBITDA and free cash flow anomalies) that reduce confidence in trend quality.

Income Statement

Profitability is strong and improving in absolute terms, with net income rising from ~€0.88B (2020) to ~€2.64B (2025). Net profit margin is positive but volatile (roughly ~4–10% in 2020/2021/2025, but unusually high in 2022–2024), and operating profit measures are inconsistent (e.g., 2025 shows zero EBIT/EBITDA), which reduces confidence in trend quality. Revenue growth rates also swing sharply year to year, suggesting lumpiness and/or reporting inconsistencies in the revenue line.

Balance Sheet

Balance sheet leverage looks reasonable for a reinsurer, with debt-to-equity improving over time (about 0.61 in 2022 down to ~0.32 in 2025) and equity steadily building (from ~€9.1B in 2022 to ~€12.9B in 2025). Returns on equity are consistently healthy and have trended up (~8.6% in 2022 to ~20% in 2025), pointing to good capital efficiency. A key watch item is that total assets remain large and fluctuate meaningfully year to year, so maintaining capital strength through the cycle remains important.

Cash Flow

Operating cash flow is consistently strong and stable (roughly ~€3.0B to ~€5.8B from 2020–2025), which supports earnings quality. Free cash flow is solid in 2020–2024 and tracks net income closely (free cash flow to net income shown as 1.0 in those years), but 2025 reports zero free cash flow and negative free cash flow growth, indicating either a one-off working capital/investment swing or a data/reporting gap. Operating cash flow versus net income coverage is strong in several years, though the 2025 coverage reads as zero, again suggesting an anomaly that tempers the score.

Breakdown	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	26.80B	2.66B	21.98B	1.39B	26.28B
Gross Profit	26.80B	2.53B	21.35B	1.31B	26.28B
EBITDA	0.00	3.37B	2.01B	1.44B	1.71B
Net Income	2.64B	2.33B	1.82B	780.80M	1.23B
Balance Sheet
Total Assets	71.33B	72.13B	65.67B	62.96B	82.90B
Cash, Cash Equivalents and Short-Term Investments	1.05B	57.39B	1.05B	48.81B	49.19B
Total Debt	4.14B	4.67B	4.88B	5.51B	4.37B
Total Liabilities	57.40B	59.44B	54.65B	53.00B	70.15B
Stockholders Equity	12.93B	11.79B	10.13B	9.06B	11.89B
Cash Flow
Free Cash Flow	0.00	5.68B	5.79B	4.95B	4.94B
Operating Cash Flow	5.69B	5.68B	5.79B	4.95B	4.94B
Investing Cash Flow	-4.05B	-4.41B	-4.51B	-5.08B	-5.26B
Financing Cash Flow	-1.72B	-1.10B	-1.50B	44.30M	277.51M

Hannover Rueck Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 273.80
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Negative
• STOCH: Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For DE:HNR1, the sentiment is Positive. The current price of 273.8 is above the 20-day moving average (MA) of 253.34, above the 50-day MA of 247.32, and above the 200-day MA of 255.86, indicating a bullish trend. The MACD of 4.02 indicates Negative momentum. The RSI at 72.32 is Negative, neither overbought nor oversold. The STOCH value of 92.79 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for DE:HNR1.

Hannover Rueck Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
HNR1	74 Outperform	€33.01B	12.16	21.34%	3.37%	2.57%	9.75%
MUV2	71 Outperform	€72.30B	8.78	19.40%	3.56%	0.48%	11.17%
Sector *	68 Neutral	$18.00B	11.42	9.92%	3.81%	9.73%	1.22%
ALV	67 Neutral	€137.13B	13.65	―	3.94%	25.33%	12.54%
TLX	67 Neutral	€28.50B	12.37	19.37%	2.37%	3.70%	24.02%